Bogdan Draganski1, Kailash P Bhatia. 1. Departement des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. bogdan.draganski@gmail.com
Abstract
PURPOSE OF REVIEW: An overview of recent advances in structural neuroimaging and their impact on movement disorders research is presented. RECENT FINDINGS: Novel developments in computational neuroanatomy and improvements in magnetic resonance image quality have brought further insight into the pathophysiology of movement disorders. Sophisticated automated techniques allow for sensitive and reliable in-vivo differentiation of phenotype/genotype related traits and their interaction even at presymptomatic stages of disease. SUMMARY: Voxel-based morphometry consistently demonstrates well defined patterns of brain structure changes in movement disorders. Advanced stages of idiopathic Parkinson's disease are characterized by grey matter volume decreases in basal ganglia. Depending on the presence of cognitive impairment, volume changes are reported in widespread cortical and limbic areas. Atypical Parkinsonian syndromes still pose a challenge for accurate morphometry-based classification, especially in early stages of disease progression. Essential tremor has been mainly associated with thalamic and cerebellar changes. Studies on preclinical Huntington's disease show progressive loss of tissue in the caudate and cortical thinning related to distinct motor and cognitive phenotypes. Basal ganglia volume in primary dystonia reveals an interaction between genotype and phenotype such that brain structure changes are modulated by the presence of symptoms under the influence of genetic factors. Tics in Tourette's syndrome correlate with brain structure changes in limbic, motor and associative fronto-striato-parietal circuits. Computational neuroanatomy provides useful tools for in-vivo assessment of brain structure in movement disorders, allowing for accurate classification in early clinical stages as well as for monitoring therapy effects and/or disease progression.
PURPOSE OF REVIEW: An overview of recent advances in structural neuroimaging and their impact on movement disorders research is presented. RECENT FINDINGS: Novel developments in computational neuroanatomy and improvements in magnetic resonance image quality have brought further insight into the pathophysiology of movement disorders. Sophisticated automated techniques allow for sensitive and reliable in-vivo differentiation of phenotype/genotype related traits and their interaction even at presymptomatic stages of disease. SUMMARY: Voxel-based morphometry consistently demonstrates well defined patterns of brain structure changes in movement disorders. Advanced stages of idiopathic Parkinson's disease are characterized by grey matter volume decreases in basal ganglia. Depending on the presence of cognitive impairment, volume changes are reported in widespread cortical and limbic areas. Atypical Parkinsonian syndromes still pose a challenge for accurate morphometry-based classification, especially in early stages of disease progression. Essential tremor has been mainly associated with thalamic and cerebellar changes. Studies on preclinical Huntington's disease show progressive loss of tissue in the caudate and cortical thinning related to distinct motor and cognitive phenotypes. Basal ganglia volume in primary dystonia reveals an interaction between genotype and phenotype such that brain structure changes are modulated by the presence of symptoms under the influence of genetic factors. Tics in Tourette's syndrome correlate with brain structure changes in limbic, motor and associative fronto-striato-parietal circuits. Computational neuroanatomy provides useful tools for in-vivo assessment of brain structure in movement disorders, allowing for accurate classification in early clinical stages as well as for monitoring therapy effects and/or disease progression.
Authors: Sheng-Han Kuo; Guomei Tang; Elan D Louis; Karen Ma; Rachel Babji; Matthew Balatbat; Etty Cortes; Jean-Paul G Vonsattel; Ai Yamamoto; David Sulzer; Phyllis L Faust Journal: Acta Neuropathol Date: 2013-03-31 Impact factor: 17.088
Authors: Peter Redgrave; Manuel Rodriguez; Yoland Smith; Maria C Rodriguez-Oroz; Stephane Lehericy; Hagai Bergman; Yves Agid; Mahlon R DeLong; Jose A Obeso Journal: Nat Rev Neurosci Date: 2010-10-14 Impact factor: 34.870
Authors: Derek E Neilson; Michael Zech; Robert B Hufnagel; Jesse Slone; Xinjian Wang; Shelli Homan; Lisa M Gutzwiller; Elizabeth J Leslie; Nancy D Leslie; Jianfeng Xiao; Peter Hedera; Mark S LeDoux; Brian Gebelein; Friederike Wilbert; Matthias Eckenweiler; Juliane Winkelmann; Donald L Gilbert; Taosheng Huang Journal: Mov Disord Date: 2021-10-11 Impact factor: 10.338
Authors: Tyler C Duffield; Haley G Trontel; Erin D Bigler; Alyson Froehlich; Molly B Prigge; Brittany Travers; Ryan R Green; Annahir N Cariello; Jason Cooperrider; Jared Nielsen; Andrew Alexander; Jeffrey Anderson; P Thomas Fletcher; Nicholas Lange; Brandon Zielinski; Janet Lainhart Journal: J Clin Exp Neuropsychol Date: 2013-08-28 Impact factor: 2.475
Authors: Giovanni Battistella; Eleonora Fornari; Jean-Marie Annoni; Haithem Chtioui; Kim Dao; Marie Fabritius; Bernard Favrat; Jean-Frédéric Mall; Philippe Maeder; Christian Giroud Journal: Neuropsychopharmacology Date: 2014-03-17 Impact factor: 7.853